CARLSBAD, Calif. & NORWALK, Conn.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ: IVGN) and Applied Biosystems Inc. (NYSE: ABI) today announced that the registration statement, including a joint proxy statement/prospectus, for their proposed merger has become effective. The companies expect to commence mailing the joint proxy statement/prospectus and all relevant materials to shareholders this week.
